
Blackstone Strategic Credit 2027 Term Fund is a close ended fixed income mutual fund launched and managed by GSO / Blackstone Debt Funds Management LLC. It invests in the fixed income markets of the United States. The fund seeks to invest in stocks of companies operating across diversified sectors. It primarily invests in the loans and other fixed income instruments including first- and second-lien secured loans and high-yield corporate bonds of different maturities. The fund employs fundamental analysis using a research-driven credit analysis approach while focusing on factors like companies…

BeOne Medicines AG is a fast-growing oncology company and a Wall Street favorite. Tevimbra, its PD-1 inhibitor, helped drive growth, with Q2 revenue rising 10.8% QoQ and 18.1% YoY to $228.5 million. BeOne's rich pipeline includes BGB-B2033, BG-C477, and BGB-58067, with clinical data scheduled for presentation at the 2026 ESMO Congress, taking place October 23-27.

Blackstone Strategic Credit 2027 Term Fund offers a floating-rate, high-yield portfolio with a current ~5% discount and ~8% yield. BGB's term structure is set for potential liquidation in under a year, creating a likely catalyst for discount narrowing via liquidation or a 100% NAV tender offer. Potential distribution increases may follow further Fed hikes, enhancing BGB's income appeal as well.

Our Triple-Factor screen identifies closed-end funds combining a yield above 6.5%, distribution coverage above 90%, and a discount to NAV, screening over 400 CEFs as of the close of September 15, 2026. Portfolio holdings Highland Opportunities and Income (HFRO), BNY Mellon High Yield Strategies (DHF), PIMCO Dynamic Income Opportunities (PDO), and Blackstone Strategic Credit 2027 (BGB) all rank among this month's top lists. As a reminder, these top lists are meant to be preliminary shortlists for further research, and are not meant to be the final analysis for a buy or sell decision.

Blackstone Strategic Credit 2027 Term offers a widened discount exceeding 5.5%, now above our "Buy" threshold, prompting an upgrade. BGB's term structure and anticipated 2027 liquidation create a tactical opportunity, with a recent investment from a large institutional CEF investment group. The fund's floating-rate, senior secured loan portfolio provides diversification but carries leveraged below-investment-grade credit risk.

The Income-Covered Closed-End Fund Report screens for CEFs with distribution coverage exceeding 100%, targeting funds less likely to cut payouts. Discounted, fully-covered CEFs offer dual benefits: potential price appreciation from narrowing discounts and enhanced yields based on full NAV distributions. Composite metrics combining yield, discount, and z-score help identify CEFs offering value on both absolute and relative terms, with high income potential.